NDC to RxNorm Crosswalk 66019-310 Flumist Quadrivalent

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 66019-310 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Flumist Quadrivalent . The unique RxCUI concepts linked to this product are: 2645086 and 2645092. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 2645086

Concept: influenza virus vaccine 2023-2024 Quadrivalent Nasal Spray: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Norway/31694/2022 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 2645092

Concept: FluMist Quadrivalent, 2023-2024 Formula Nasal Spray: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Norway/31694/2022 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2023-2024]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: FluMist Quadrivalent, 2023-2024 Formula Nasal Spray: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.